NCT02244047View on ClinicalTrials.gov

Cytokine Profile in Children With Celiac Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Celiac Disease
Interventions
DRUG

Bifidobacterium breve

DRUG

Placebo (for Bifidobacterium breve)

All Listed Sponsors
collaborator

Slovenian Research Agency

OTHER

lead

University Medical Centre Maribor

OTHER

NCT02244047 - Cytokine Profile in Children With Celiac Disease | Biotech Hunter | Biotech Hunter